-
Critical care medicine 11/2010; 38(11):2257-8. · 6.37 Impact Factor
-
Stephen Derdak
Critical care medicine 05/2008; 36(4):1358-60. · 6.37 Impact Factor
-
Critical Care Medicine 09/2007; 35(10):2473. · 6.33 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Ventilator settings typically used for high-frequency oscillatory ventilation (HFO) in adults provide acceptable gas exchange but may not take best advantage of its lung-protective aspects. We provide guidelines for HFO in adults with acute respiratory distress syndrome that should optimize the lung-protective characteristics of this ventilation mode.
Roundtable discussions, iterative revisions, and consensus.
Five academic medical centers.
Not applicable.
Participants addressed how to best maintain ventilation through combinations of oscillation pressure amplitude, frequency, and the use of an endotracheal tube cuff leak, and to maintain oxygenation through combinations of recruitment maneuvers, mean airway pressure, and oxygen concentration. The guiding principles were to provide lung protective ventilation by minimizing the size of tidal volumes, and balance the risks and benefits of lung recruitment and distension.
HFO may provide smaller tidal volumes and more complete lung recruitment than conventional modes. To optimize these features, we recommend use of the maximum pressure-oscillation amplitude coupled with the highest tolerated frequency, targeting a pH of only 7.25-7.35. This will yield a smaller tidal volume than typical HFO settings where frequency is limited to 6 Hz or less and pressure amplitude is submaximal. Lung recruitment can be achieved with the use of recruitment maneuvers, especially during the first several days of HFO. Recruitment may be augmented or sustained with generous mean airway pressures. These may either be chosen from a table of recommended mean airway pressure and oxygen concentration combinations, or individually titrated based on the oxygenation response of each patient.
Modification of the goals and tactics of HFO use may better protect against ventilator-associated lung injury. Further clinical trials are needed to compare the effects on patient outcome of the best use of HFO compared to the most protective use of conventional modes in adult acute respiratory distress syndrome.
Critical Care Medicine 08/2007; 35(7):1649-54. · 6.33 Impact Factor
-
Stephen Derdak
The Journal of trauma 07/2007; 62(6 Suppl):S58. · 2.48 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: To summarize the pathophysiology and treatment of acute lung injury and acute respiratory distress syndrome (ARDS) during pregnancy.
Review of select articles from MEDLINE, including published abstracts, case reports, observational studies, controlled trials, review articles, and institutional experience.
ARDS occurs in pregnancy and may have unique causes. Despite extensive clinical research to improve the management of ARDS, mortality remains high, and few strategies have shown a mortality benefit. Furthermore, in most published studies, pregnancy is an exclusionary criterion, and thus, few treatments have been adequately evaluated in obstetric populations. The treatment of ARDS in pregnancy is extrapolated from studies performed in the general ARDS patient population, with consideration given to the normal physiologic changes of pregnancy. In general, the best support of the fetus is support of the mother. From the age of viability (24-26 wks at most institutions) until full term, decisions regarding delivery should be made based primarily on the standard obstetric indications.
Little evidence exists regarding the management of ARDS specifically in pregnancy, and thus, treatment approaches must be drawn from studies performed in a general patient population. A multidisciplinary approach involving maternal-fetal medicine, neonatology, anesthesiology, and intensivist clinicians is essential to optimizing maternal and fetal outcomes.
Critical Care Medicine 11/2005; 33(10 Suppl):S269-78. · 6.33 Impact Factor
-
Stephen Derdak
Critical Care Medicine 04/2005; 33(3 Suppl):S113-4. · 6.33 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: To summarize clinical information and assessment techniques relevant to respiratory therapists caring for adult patients on high-frequency oscillatory ventilation (HFOV).
Review of observational studies, controlled trials, case reports, institutional experience, and hospital HFOV guidelines for adult patients.
Respiratory therapists require unique physical assessment skills and knowledge in managing patients on HFOV. Respiratory therapy procedures relevant to HFOV include setting endotracheal tube cuff leaks, performing lung recruiting maneuvers, endotracheal suctioning, and monitoring ventilator parameters. Respiratory therapists serve as essential team members in the creation and implementation of written HFOV guidelines (e.g., algorithms) to optimize patient care.
Respiratory therapy assessment and procedural skills are essential in providing optimal care to adult patients on HFOV.
Critical Care Medicine 04/2005; 33(3 Suppl):S196-203. · 6.33 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Review data obtained from high-frequency oscillatory ventilation (HFOV) and mechanical test lung models with respect to delivered tidal volume, distal pressure transmission, endotracheal tube cuff leaks, and simulated clinical conditions.
Review of selected studies from PubMed, published abstracts, and institutional mechanical test lung data.
Tidal volume delivery during HFOV is altered by oscillatory pressure amplitude (DeltaP), frequency (Hz), percent inspiratory time (IT%), and patient variables. Distal (carinal) oscillatory pressure amplitude transmission is directly correlated with endotracheal tube diameter and peripheral airway resistance. Endotracheal tube cuff leaks promote egress of tracheal gas while attenuating distal oscillatory pressure amplitude and tidal volume transmission. Simulated clinical conditions (e.g., increased distal airway resistance, mainstem intubation) may increase observed DeltaP, whereas mean airway pressure is decreased with air leaks.
Mechanical test lung and artificial trachea simulations may provide useful information on the interaction of HFOV with altered lung mechanics and may contribute to the formulation of HFOV clinical strategies. Important limitations of these models include absence of gas exchange, histologic and biologic markers, or hemodynamic data.
Critical Care Medicine 04/2005; 33(3 Suppl):S142-7. · 6.33 Impact Factor
-
New England Journal of Medicine 12/2003; 349(19):1829. · 53.30 Impact Factor
-
Stephen Derdak
[show abstract]
[hide abstract]
ABSTRACT: High-frequency oscillatory ventilation (HFOV) using an open-lung strategy has been demonstrated to improve oxygenation in neonatal and pediatric respiratory failure, without increasing barotrauma. Animal studies using small (<4 mm) endotracheal tubes have shown reduced histopathologic evidence of lung injury and inflammatory mediator release, suggesting reduced ventilator-induced lung injury.
During the last decade, case reports and observational studies of HFOV in patients failing conventional ventilation strategies have suggested improved oxygenation in adult patients with severe acute respiratory distress syndrome. These reports have also suggested that early (2 days) initiation of HFOV is more likely to result in survival than delayed initiation (>7 days). A recently published randomized, controlled trial in acute respiratory distress syndrome patients (n = 148) comparing HFOV with a pressure-control ventilation strategy (Pao(2)/Fio(2) ratio of <or=200 mm Hg on positive end-expiratory pressure of >10 cm H(2)O) demonstrated early (<16 hrs) improvement in Pao(2)/Fio(2) (p =.008) in the HFOV group but no significant difference in oxygenation index between the two groups during the initial 72 hrs of treatment. Thirty-day mortality was 37% in the HFOV group and 52% in the conventional ventilation group (p =.102). There was no significant difference between treatment groups in the prevalence of barotrauma, hemodynamic instability, or mucus plugging. This study suggests that HFOV is as effective and safe as the conventional strategy to which it was compared. CLINICAL APPLICATION: For clinical use in adults, a trial of HFOV may be considered when Fio(2) requirements exceed 60% and mean airway pressure is approaching 20 cm H(2)O or higher (or, alternatively, positive end-expiratory pressure of >15 cm H(2)O). It is currently unknown whether initiating HFOV at a lower severity threshold would result in reduced ventilator-associated lung injury or mortality.
Future studies should compare different algorithms of applying HFOV to determine the optimal techniques for achieving oxygenation and ventilation, while minimizing ventilator-associated lung injury. The potential role of adjunctive therapies used with HFOV (e.g., prone ventilation, inhaled nitric oxide, aerosolized vasodilators, liquid ventilation) will require further research.
Critical Care Medicine 04/2003; 31(4 Suppl):S317-23. · 6.33 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: To review minimally invasive cardiac output monitoring devices currently available for use in the intensive care unit.
Medline search from 1966 to present plus cited reference studies and abstracts from available product literature.
Selection criteria included published reports and abstracts comparing the accuracy of minimally invasive cardiac output monitors to a "gold standard."
Many reports have been published on the accuracy of individual minimally invasive cardiac output monitors, but cumulative data reviewing each type of monitor have not been synthesized and made available to the clinician.
Emerging noninvasive or minimally invasive means of cardiac output monitoring are based on varied physiologic principles and can be used for following hemodynamic trends. Each of these methods has advantages and disadvantages; it is important for the clinician to understand the strengths and limitations of each device to effectively use the information derived.
Critical Care Medicine 11/2002; 30(10):2338-45. · 6.33 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Observational studies of high-frequency oscillatory ventilation in adults with the acute respiratory distress syndrome have demonstrated improvements in oxygenation. We designed a multicenter, randomized, controlled trial comparing the safety and effectiveness of high-frequency oscillatory ventilation with conventional ventilation in adults with acute respiratory distress syndrome; 148 adults with acute respiratory distress syndrome (Pa(O2)/fraction of inspired oxygen <or= 200 mm Hg on 10 or more cm H2O positive end-expiratory pressure) were randomized to high-frequency oscillatory ventilation (n = 75) or conventional ventilation (n = 73). Applied mean airway pressure was significantly higher in the high-frequency oscillation group compared with the conventional ventilation group throughout the first 72 hours (p = 0.0001). The high-frequency oscillation group showed early (less than 16 hours) improvement in Pa(O2)/fraction of inspired oxygen compared with the conventional ventilation group (p = 0.008); however, this difference did not persist beyond 24 hours. Oxygenation index decreased similarly over the first 72 hours in both groups. Thirty-day mortality was 37% in the high-frequency oscillation group and was 52% in the conventional ventilation group (p = 0.102). The percentage of patients alive without mechanical ventilation at Day 30 was 36% and 31% in the high-frequency oscillation and conventional ventilation groups, respectively (p = 0.686). There were no significant differences in hemodynamic variables, oxygenation failure, ventilation failure, barotraumas, or mucus plugging between treatment groups. We conclude that high-frequency oscillation is a safe and effective mode of ventilation for the treatment of acute respiratory distress syndrome in adults.
American Journal of Respiratory and Critical Care Medicine 09/2002; 166(6):801-8. · 11.08 Impact Factor
